457 related articles for article (PubMed ID: 17068620)
41. Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes.
Xu X; Shi Y; Cui Y; Ma J; Che L; Chen ZJ
Clin Endocrinol (Oxf); 2012 Mar; 76(3):425-30. PubMed ID: 21815904
[TBL] [Abstract][Full Text] [Related]
42. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
Grulet H; Hecart AC; Delemer B; Gross A; Sulmont V; Leutenegger M; Caron J
Clin Endocrinol (Oxf); 1993 Jun; 38(6):621-6. PubMed ID: 8334748
[TBL] [Abstract][Full Text] [Related]
43. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
44. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
Mejia-Montilla J; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Bravo-Henríquez A
Endocrinol Nutr; 2012 Jan; 59(1):21-7. PubMed ID: 22115703
[TBL] [Abstract][Full Text] [Related]
45. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
46. A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome.
Shah AK; Yadav BK; Suri A; Shah AK
Horm Mol Biol Clin Investig; 2022 Sep; 43(3):357-361. PubMed ID: 35439403
[TBL] [Abstract][Full Text] [Related]
47. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
48. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
49. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
50. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
[TBL] [Abstract][Full Text] [Related]
51. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D
Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223
[TBL] [Abstract][Full Text] [Related]
52. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
[TBL] [Abstract][Full Text] [Related]
53. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome.
Gonzalez F; Thusu K; Abdel-Rahman E; Prabhala A; Tomani M; Dandona P
Metabolism; 1999 Apr; 48(4):437-41. PubMed ID: 10206434
[TBL] [Abstract][Full Text] [Related]
54. [Study on the correlation between different Chinese medicine syndrome types and endocrine metabolism of polycystic ovarian syndrome].
Wang XJ; Zeng XL; Liu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1085-9. PubMed ID: 21910340
[TBL] [Abstract][Full Text] [Related]
55. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
56. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
[TBL] [Abstract][Full Text] [Related]
57. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
58. Impact of obesity on lipid profiles in middle-aged women.
Maksvytis A; Stakisaitis D
Medicina (Kaunas); 2004; 40(6):553-7. PubMed ID: 15208478
[TBL] [Abstract][Full Text] [Related]
59. The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome.
Chen J; Shen S; Tan Y; Xia D; Xia Y; Cao Y; Wang W; Wu X; Wang H; Yi L; Gao Q; Wang Y
J Ovarian Res; 2015 Mar; 8():11. PubMed ID: 25881575
[TBL] [Abstract][Full Text] [Related]
60. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
